Licensing opportunities
Here is an overview of Inven2s existing licensing opportunities divided into eight technology categories. Each licensing opportunity is described in more detail featuring business opportunity, technology, advantages, contact information and other relevant information.
Method for modifying gut microbiota
Scientists at Norwegian University of Life Sciences and University of Copenhagen have developed a unique soil bacterium and ... Read more
Light-modified cryoprobe for eye surgery
Background Retinal detachment generally occurs when fluid travels through a retinal tear and causes the retina to detach from the ... Read more
Conversion of CO2 to valuable chemicals
Business opportunity Transformation of C1 molecules (CO, CO2, CH4, CH3OH, and HCOOH) play an important role in providing energy and ... Read more
Optimized Medical Suction Tip for Surgical Precision and Speed
Business opportunity In everyday surgical practice, accidental and uncontrollable bleeding during surgery can entail high risk of ... Read more
Triple fluorescence UPR reporter cell line
BUSINESS OPPORTUNITY We have developed a cell line that simultaneously reports on the three arms of the Unfolded Protein Response ... Read more
CA125 domain of MUC16 as a novel target to treat ovarian cancer
Background Ovarian cancer is the leading cause of death from gynaecological malignancies in the Western world. CAR-T cell therapy has ... Read more
Switch receptor for use in adoptive cell therapy
Business opportunity Therapy employing T cells modified with chimeric antigen receptors (CARs) is effective in hematological ... Read more
DogBiTE to treat canine osteosarcoma
Background Dogs spontaneously develop cancer just like humans. Canine osteosarcoma is an aggressive bone tumour with high rate of ... Read more
Neoantigen-specific TCR, Radium-1, for treatment of solid malignancies
Background Colorectal cancer (CRC) is the third most common cancer worldwide. Despite fair survival for localized CRC, metastatic CRC ... Read more
Lumiblast™
A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible ... Read more
Biomarker for de-escalating adjuvant chemotherapy in breast cancer
BUSINESS OPPORTUNITY Leading scientists at the Oslo University Hospital have identified a unique biomarker in patients with ... Read more
Multilumen glaucoma surgery stent
Background Glaucoma is a multifactorial optic neuropathy characterized by progressive damage to the optic nerve, which results in the ... Read more
Novel peptide with very strong endotoxin binding
BUSINESS OPPORTUNITY Lipopolysaccharides (LPS) or endotoxins are an important part of the outer membrane of Gram-negative bacteria. ... Read more
Rapeseed trait reducing seed loss
BUSINESS OPPORTUNITY Rapeseed (canola, Brassica napus) is the second largest oil crop in the world. Accounting for about 16% of the ... Read more
Tuned CAR-T cells – a platform technology
Poor persistence of the T-cell product represents an important challenge with CAR-T cell therapy. This is often due to constitutive ... Read more
TANDEMAb: IgA-IgG fusions with tailored effector functions
Business opportunity Monoclonal antibodies have revolutionized treatment, especially for cancer and autoimmune diseases. However, a ... Read more
A neural network based denoising system
Business Opportunity Scientists from the Institute for Experimental Medical Research at the University of Oslo are developing ... Read more
Bio-engineered palladium nanoparticles
Business opportunity Palladium nanoparticles (Pd NPs) have a wide range of applications in for example catalysis, sensors, fuel cells ... Read more
3D cell culture model for differentiated natural osteocytes without artificial additives
BUSINESS OPPORTUNITY Well-functioning in-vitro models of human osteocytes are lacking. Scientists at the University of Oslo and Oslo ... Read more
Novel applications of VAS for treatment and prevention of cardiorenal damage
Business opportunity Scientists from Oslo University Hospital and University of Oslo observed that Vastiras (VAS), a cardiac hormone ... Read more
Early detection of brain-tumor progression
Business opportunity Brain tumors are one of the deadliest forms of cancer and the primary goal of treatment is simply to decelerate ... Read more
Non-Invasive Diagnostic Tool for Heart Failure
Business opportunity Heart failure is one of the most prevalent heart diseases, affecting over 64 million people worldwide, and has a ... Read more
Solid Electrolyte Interface Stabilizers for Li-ion batteries
Business opportunity Leading scientists at the Dept. of Chemistry, Univ. of Oslo have developed additives for silicon ... Read more
CAR-T for p95HER2-positive breast cancer patients resistant to antibody treatments targeting HER2
Business opportunity About 50% of human epidermal growth factor receptor 2 (HER2)-positive tumors express p95HER2, a known ... Read more
A urine test for detection and monitoring of bladder cancer
BUSINESS OPPORTUNITY Scientists at Oslo University Hospital are developing a urine based test, addressing a major unmet need for ... Read more
Scalable Pump-less organ-on-a-chip platform with directed flow
Business opportunity Scientists at the University of Oslo (Norway) have developed an innovative, scalable directional ... Read more
siRNA drug targeting MTHFD2 for treatment of prostate cancer
Scientists at University of Oslo have identified a mitochondrial enzyme, MTHFD2, as a potential therapeutic target in prostate cancer ... Read more
MIGS glaucoma device with multiple channels
BACKGROUND Improved management of glaucoma Glaucoma is a multifactorial optic neuropathy characterized by progressive damage to ... Read more
STEAP1 CAR for metastatic prostate cancer
Business opportunity Scientists at Oslo University Hospital (Norway) have developed a new chimeric antigen receptor (CAR) targeting ... Read more
HLA-II targeting vaccines
Our team at Oslo University Hospital and University of Oslo has developed a novel targeting sequence that allows for direct targeting ... Read more
AI-based segmentation of vascular structures
Business opportunity Scientists at the Inst. of Clin. Med., Univ. of Oslo, Akershus Univ. Hospital, and Faculty of Med., Univ. of ... Read more
CAR T-cell Therapy for Osteosarcoma (OSCAR)
Business opportunity The present technology has the potential to effectively treat children and adults with metastatic osteosarcoma ... Read more
Novel therapy for currently untreatable hypertension
Business opportunity Resistant hypertension (RHT) is a frequent disease and causes premature morbidity and death. RHT is defined as ... Read more
Needle-I – “seeing” what tissue types surround a needle tip
A method to discriminate nerve tissue from other tissue types and detect intraneural needle placement in peripherial nerve blocks with very high sensitivity and specificity (ROC=97% in animal model). Clinical studies in humans are needed to confirm the results. Read more
Faster and better image processing in radar, sonar and ultrasound
A software beamforming method that reduces the ultrasound data processing time and complexity dramatically. Read more
Very high production rates of medical radio isotopes with cyclotrons
A target holder, target formulation technology, and a cyclotron production process allowing intense target irradiation and very high output of medical radio isotopes. Read more
Therapeutic regulation of WNT/YAP-signaling through a potent and specific tankyrase inhibitor
A class of novel WNT/YAP inhibitor compounds exhibiting high specificity for tankyrase and demonstrated proof of concept in mouse models for several cancer indications. Read more
Sensitive ChIP-seq method for the study of single cells and small pools of cells
A sensitive ChIP-seq method for the study of single cells and small pools of cells to reveal where specific proteins or modified histones are bound throughout the genome. Read more
An optimized engineered albumin for half-life extension and mucosal delivery of biologics
An engineered human albumin variant with extended in vivo half-life. Read more
AlbuVAX – A novel mucosal delivery technology for subunit vaccines
A novel technology for enhanced uptake of subunit vaccines across mucosal barriers. Read more
A versatile improved antibody Fc technology platform
A unique and versatile antibody Fc technology platform (“REW”). Read more
MetaGate – For fast and simple analysis of complex single-cell data
Recent advances in flow and mass cytometers have enabled assessment of more parameters. Read more
AnaConDebt – Analysis of Contagious technical Debt
Technical debt in software development consists of sub-optimal design solutions that are beneficial in the short term, but create costly negative impact in the long run, e.g. costly maintenance changes and impossibility to evolve the system. Read more
Highly Epitaxial Metallic Oxides at Low Thermal Budget
A production method for materials with very high conductivity targeting the key challenges in the electronics industry Read more